Company Details
  • Conbott Pharmtech Co.,Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Mark: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
  • Exporter:71% - 80%
  • Certs:COS, ISO9001, ISO14010, FDA
  • Description:849217-68-1,CAS 849217-68-1,CAS Number 849217-68-1
Conbott Pharmtech Co.,Ltd. 849217-68-1,CAS 849217-68-1,CAS Number 849217-68-1
Home > Products > Inhibitors > VEGFR Inhibitors > VEGFR Inhibitor Cabozantinib CAS 849217-68-1
Title
  • Title
  • All
Online Service
http://www.conbottpharm.comScan to visit

VEGFR Inhibitor Cabozantinib CAS 849217-68-1

Share to:  
    Payment Type: L/C,T/T
    Min. Order: 1 Gram
    Delivery Time: 10 Days

Basic Info

Model No.: 849217-68-1

Additional Info

Packaging: AS Required

Productivity: Customized

Brand: CONBOTTPHARM

Transportation: Ocean,Air

Place of Origin: CHINA

Supply Ability: Commercial

Certificate: DOCUMENT SUPPORT

Product Description

Cabozantinib as known as CABXL-184 CAS number 849217-68-1 which Is a novel multi-target tyrosine kinase inhibitor, as a regulator of MET, vascular endothelial growth factor receptor 2 (VEGFR2) and RET tyrosine Kinase Inhibitors that can block the development and progression of tumor cells and are clinically used in the treatment of patients with progressive, metastatic thyroid medullary carcinoma (MTC). In vitro biochemical and cytological analysis showed that Cabozantinib can inhibit a variety of kinase activity and play an anti-tumor effect, kill tumor cells, reduce metastasis and inhibit tumor angiogenesis. patients treated with Cabozantinib,the incidence of gastrointestinal perforation and fistula formation was 3% and 1% respectively, For patients with perforation or fistula formation, Cabozantinib CAS 849217-68-1 should be terminated immediately. A large number of clinical experimental data show that the efficacy of Cabozantinib is significantly better than everolimus.

Thera. Category: Anti cancer

Cas No.: 849217-68-1

Synonym: XL-184 free base (Cabozantinib);BMS907351;N-(4-((6,7-DiMethoxyquino;N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;Cabozantinib;N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;XL184;Cabozantinib(XL184);

849217-68-1

Molecular Formula:C28H24FN3O5

Molecular Weight: 502

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage: Synthesis Pharmaceutical Intermediates


Looking for ideal 849217-68-1 Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the CAS 849217-68-1 are quality guaranteed. We are China Origin Factory of CAS Number 849217-68-1. If you have any question, please feel free to contact us.

Product Categories : Inhibitors > VEGFR Inhibitors

Product Images
  • VEGFR Inhibitor Cabozantinib CAS 849217-68-1
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Copyright © 2019 Conbott Pharmtech Co.,Ltd. All rights reserved.
Communicate with Supplier?Supplier
Tommy Mr. Tommy
What can I do for you?